article thumbnail

FDA approves Lyumjev® (insulin lispro-aabc injection) 100 units/mL for use in insulin pumps

The Pharma Data

approval of pump use for Lilly’s novel insulin is latest development designed to help people with diabetes manage blood sugar levels. Lyumjev, a novel formulation of insulin lispro developed to speed the absorption of insulin into the bloodstream and reduce A1C levels, was approved by the FDA in June 2020.

Insulin 52
article thumbnail

Novo Nordisk launches first smart insulin pens for NHS patients

pharmaphorum

Novo Nordisk has made its smart insulin pens available in the UK, giving people treated within the NHS for diabetes access to devices that can monitor and record dosing information for the first time. Smart insulin pens are expected to drive the insulin pen market from $13.8

Insulin 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Longevity Breakthrough Your Doctor Won't Tell You About

The Pharma Data

Product Name: The Longevity Breakthrough Your Doctor Won't Tell You About. Click here to get The Longevity Breakthrough Your Doctor Won't Tell You About at discounted price while it’s still available… All orders are protected by SSL encryption – the highest industry standard for online security from trusted vendors.

Doctors 52
article thumbnail

Enabling the next wave of innovative drug therapies with speciality enzymes

Pharmaceutical Technology

The next wave of medicine is well on course to be cell and gene-based. In September 2021, GlobalData figures revealed there to be 1,320 industry-sponsored regenerative medicine and advanced therapy trials ongoing worldwide. Meanwhile, the pharma industry is undergoing somewhat of a transformation itself.

Drugs 295
article thumbnail

Treatment Reverses Young Man’s Type 1 Diabetes. Will It Last?

The Pharma Data

7, 2020 — After starting a drug that’s officially approved to treat a type of blood cancer, a young man with type 1 diabetes was able to stop using insulin. He’s been off insulin since August 2018 — more than two years. Dr. Lisa Forbes — his doctor and co-author of a letter describing his case in the Oct.

Insulin 52
article thumbnail

Australian discovery boosts hopes of preventing Type 1 diabetes

Drug Discovery World

Type 1 diabetes is a potentially life-threatening chronic condition in which the pancreas produces little or no insulin. We found boosting the regulatory T-cells using sRAGE in the pancreas, pancreatic lymph nodes and spleen prevented diabetes, and also resulted in better insulin expression and function,” Dr Leung said.

Insulin 52
article thumbnail

Nine for 2023, part three: thriving or surviving?

pharmaphorum

This in itself is not problematic: studies of impact and perception of virtual versus face-to-face engagement show doctors use them for different purposes (for example, information-focused versus relationship-focused interactions), but both have value and impact. Medicines manufacturing is energy intensive.